未登录.png)
分享.png)
收藏分享 收藏 分享 收藏 High-Plex Digital Spatial Profiling Identified Prolactin-Induced Protein mRNA Associated With Response and Survival of Everolimus and Letrozole Treatment for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer高plex数字空间分析鉴定了催乳素诱导蛋白mRNA与依维莫司和来曲唑治疗激素受体阳性/人表皮生长因子受体2阴性晚期乳腺癌的反应和生存相关。
Han, Yuhang; Ji, Danyang; Tan, Yujing; Wang, Jiayu; Ma, Fei; Luo, Yang; Lan, Bo; Zhang, Pin; Ying, Jianming; Xu, Binghe; Xue, Liyan; Fan, Ying 分享 收藏 分享 收藏 分享 收藏 分享 收藏 The ideal strategies of antibody-drug conjugate sequential treatment in HER2-expressing metastatic breast cancer: A multi-center real-world study抗体药物偶联物序贯治疗在HER2阳性转移性乳腺癌中的理想策略：一项多中心真实世界研究Peng, Xuenan; Lan, Bo; Wang, Jiayu; Li, Qiao; Wang, Jiani; Fan, Ying; Luo, Yang; Chen, Shanshan; Mo, Hongnan; Li, Lixi; Sun, Xiaoying; Zhang, Jintao; Cai, Ruigang; Zhang, Pin; Xu, Binghe; Ma, Fei 分享 收藏 Associations between sleep disturbance, treatment- related adverse events, and psychological distress in patients with breast cancer: a prospective cohort study睡眠障碍、治疗相关不良事件与乳腺癌患者心理 distress 之间的关系：一项前瞻性队列研究Li, Yuqiu; Zhao, Fang; Zhou, Yanjun; Fu, Enfeng; Zhu, Shanshan; Yu, Lulu; Xu, Hangcheng; Li, Qing; Li, Qiao; Zhang, Pin; Wang, Jiani; Mo, Hongnan 分享 收藏 分享 收藏 Major pathologic response and long-term clinical benefit in hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer after neoadjuvant chemotherapyJi, Lei; Chen, Xi; Qian, Xiaoyan; Xiao, Min; Li, Qing; Li, Qiao; Wang, Jiayu; Fan, Ying; Luo, Yang; Chen, Shanshan; Ma, Fei; Xu, Binghe; Zhang, Pin 分享 收藏 分享 收藏 Everolimus treatment in patients with hormone receptor-positive and human epidermal growth factor receptor 2-negative advanced breast cancer and a predictive model for its efficacy: a multicenter real-world study依维莫司治疗激素受体阳性和人表皮生长因子受体2阴性晚期乳腺癌患者及其疗效预测模型: 一项多中心真实世界研究Tan, Yujing; Peng, Zexi; Jiang, Hanfang; Ma, Fei; Wang, Jiayu; Zhang, Pin; Li, Qing; Tian, Xinzhu; Han, Yuhang; Ji, Danyang; Xu, Binghe; Zhao, Weihong; Fan, Ying 分享 收藏 Integrated serum pharmacochemistry, 16S rDNA sequencing, and metabolomics to reveal the material basis and mechanism of Shouhui Tongbian capsule against diphenoxylate-induced slow transit constipation in ratsYang, Jiaying; Xiao, He; Yao, Jingchun; Zhang, Pin; Yi, Bojiao; Fang, Zhengyu; Guo, Na; Guan, Yongxia; Zhang, Guimin 分享 收藏 Clinical benefit and safety profile of cross-line therapy with CDK4/6 inhibitors: a retrospective study of HR+/HER2-advanced breast cancerCDK4/6抑制剂交叉治疗的临床益处和安全性: HR /HER2-advanced乳腺癌的回顾性研究Zhao, Qi; Jiang, Mingxia; Liu, Jiaxuan; Zhang, Mengqi; He, Maiyue; Zhou, Shihan; Wang, Jiani; Mo, Hongnan; Lan, Bo; Yuan, Peng; Zhang, Pin; Ma, Fei; Li, Qiao; Xu, Binghe 分享 收藏 Inetetamab-based therapy in real-world treatment patterns with HER2-positive advanced breast cancer patients: a retrospective single-center studyJiang, Mingxia; Liu, Jiaxuan; He, Maiyue; Zhang, Mengqi; Zhou, Shihan; Chen, Shanshan; Cai, Ruigang; Mo, Hongnan; Lan, Bo; Zhang, Pin; Xu, Binghe; Li, Qiao 分享 收藏 Dalpiciclib in combination with letrozole/anastrozole or fulvestrant in HR-positive and HER2-negative advanced breast cancer: results from a phase Ib studyDalpiciclib与来曲唑/阿那曲唑或氟维司群联合治疗HR阳性和HER2-negative晚期乳腺癌: Ib期研究的结果Zhang, Qingyuan; Zhang, Pin; Yan, Min; Yan, Xi; Wang, Xian; Gu, Yuanting; Qu, Xiujuan; Li, Shaorong; Xu, Guoying; Zhu, Xiaoyu; Xu, Binghe 分享 收藏 分享 收藏 分享 收藏 Phase I/II clinical trials of LAE005, afuresertib plus nab-paclitaxel in patients with advanced solid tumors, primarily in patients with triple-negative breast cancer (TNBC)Xu, Binghe; Zhang, Pin; Wang, Ying; Tong, Zhongsheng; Yao, Tingjing; Wang, Xian; Wang, Zijia; Guo, Pengfei; Ma, Wenyue; Yue, Yong 分享 收藏 
.png){kind=icon}
.png){kind=icon}
.png)
MEDCOMM.png)
OAAI